Monographie - Iron dextran - Stabilis 4.0

Ultimo aggiornamento :
05/12/2025

Altro

Iron dextran

Iniezione

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

metodo di iniezione

Bibliografia

pdf

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cosmofer	Arabia Saudita, Colombia, Danimarca, Ecuador, Egitto, Gran Bretagna, Irlanda, Norvegia, Paesi Bassi, Portogallo, Spagna, Svezia, Venezuela
Dexferrum	Stati Uniti d’America

Bibliografia

Iniezione

Bibliografia : Iron dextran

	tipo	pubblicazione
312	Rivista	Mayhew SL, Quick MW. Compatibility of iron dextran with neonatal parenteral nutrient solutions. Am J Health-Syst Pharm 1997 ; 54: 570-571.
313	Rivista	Tu YH, Knox NL, Biringer JM, Eichman ML, Schweinsberg PD, Howard JR. Compatibility of iron dextran with total nutrient admixtures. Am J Hosp Pharm 1992 ; 49: 2233-2235.
1137	Rivista	Vaughan LM, Small C, Plunkett V. Incompatibility of iron dextran and a total nutrient admixture. Am J Hosp Pharm 1990 ; 47: 1745-1746.
1200	Rivista	Chaudry IA, Bruey KP, Hurlburt LE, Oden EM. Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives. Am J Hosp Pharm 1981 ; 38: 1737-1742.
3642	Laboratorio	Epinephrine - Résumé des Caractéristiques du Produit International Medication System (UK) 2013
4528	Rivista	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
5022	Laboratorio	CosmoFer 50mg/ml solution for infusion and injection - Summary of Product Characteristics. Pharmacosmos A/S 2023
5089	Laboratorio	Ascorbic Acid Injection 500mg/5ml - Summary of Product Characteristics Updated 04-Jan-2024 \| Phoenix Labs Phoenix Labs 2024

Mentions Légales